4th Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$1,700,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Advocate on drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries.

LobbyistCovered position, as disclosed
BILL BODE —
MICHAEL D BOYD —
CHARLES M. CLAPTON —
JAIMON JACKSON —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Advocate on drug pricing proposals and proposals to expand access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. Advocate in favor of 340B program reforms and changes. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments and therapies, including: manufacturing, clinical trials, reimbursement and coverage.

LobbyistCovered position, as disclosed
BILL BODE —
MICHAEL D BOYD —
CHARLES M. CLAPTON —
ANNA GRIFFIN —
JAIMON JACKSON —
DAVID PULLIAM —
GRACE RODDEN —
RILEY SWINEHART —
RICHARD WHITE —

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Commerce, Dept of (DOC); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Medicare/Medicaid MMM

Advocate for provisions modifying the Inflation Reduction Act and other drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies and prevention including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to hospital inpatient payments, Medicaid Drug Rebate Program, and Value-Based Purchasing arrangements including changes to best price.

LobbyistCovered position, as disclosed
BILL BODE —
MICHAEL D BOYD —
CHARLES M. CLAPTON —
ANNA GRIFFIN —
JAIMON JACKSON —
DAVID PULLIAM —
GRACE RODDEN —
RILEY SWINEHART —
RICHARD WHITE —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

LobbyistCovered position, as disclosed
BILL BODE —
CHARLES M. CLAPTON —
DAVID PULLIAM —
GRACE RODDEN —
RICHARD WHITE —

Contacted: SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Budget/Appropriations BUD

Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals.

LobbyistCovered position, as disclosed
BILL BODE —
CHARLES M. CLAPTON —
JAIMON JACKSON —
DAVID PULLIAM —
GRACE RODDEN —
RILEY SWINEHART —
RICHARD WHITE —

Contacted: Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Legislative and regulatory proposals to change international and domestic corporate tax law and policy.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —
GRACE RODDEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.